Category Archives: Events

Latest From Events

“What You Don’t Know About Partnering at the BIO World Congress, Part 2″

BIO-One-On-One

The upcoming 2016 World Congress on Industrial Biotechnology is the preeminent conference for connecting venture capital with promising industrial biotech companies. “I’ve been coming since 2007,” said Michael Krel of Sofinnova Partners in a recent conversation, “and I’ve been quite happy with partnering at World Congress, and it is very efficient.” By “partnering”, Michael is talking about the BIO One-on-One Partnering system used to setup 30-minute, private, face-to-face meetings at the conference. The system has Read More >

Environmental & Industrial, Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

What You Don’t Know About Partnering at BIO World Congress – Part 1

BIO World Congress

That partnering has taken off at World Congress is the understatement of the year. Last year there were 1,400 one-on-one meetings at World Congress, which is more than twice as many as 2013. So why the uptick? The name of the game in industrial biotech is increasingly partnering. Most innovation in the field comes from small companies. If you don’t have what it takes to do everything – create the whole value chain – partnering Read More >

Environmental & Industrial, Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

BIO CEO & Investor Conference Closes with Record Breaking Partnering Numbers

bio-ceo-2016

The 18th Annual BIO CEO & Investor Conference, the largest investor conference focused on established and emerging publicly traded and select private biotech companies, took place this earlier this week in New York City at the Waldorf Astoria with more than 1,400 registrants, including over 600 registered investors. The event featured 9 educational program sessions, including business roundtables, therapeutic workshops and plenary sessions, 6 fireside chats with biopharma CEOs as well as a special guest, New York Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

Integrating the Patient Voice: Recap of the 2016 BIO CEO & Investor Conference

CEO2013_115x75_Thumbnail copy

The 2016 BIO CEO & Investor Conference isn’t just for biotech companies and the investment community, the conference featured a strong patient voice and focus on the patient perspective in drug development and drug delivery. Two of the most highly-attended panel discussions were moderated by patient advocates. On Monday, Sue Peschin, President & Chief Executive Officer, Alliance for Aging Research, led a timely panel discussion with clinical researchers and biotech CEOs around the recent positive Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , ,

#BIOCEO16 Session Recap: Regulatory Policy Outlook—PDUFA VI and You

CEO2013_115x75_Thumbnail copy

The second day of #BIOCEO16 kicked off this morning with a look ahead to PDUFA VI and potential ways to improve the drug development and approval process. Moderated by BIO Executive Vice President of Emerging Companies Cartier Esham, the panelists included: Elizabeth Krutoholow, Analyst, Bloomberg Intelligence Jonathan Leff, Partner, Deerfield Management; Chairman, Deerfield Institute Richard F. Pops, Chairman & Chief Executive Officer, Alkermes The challenges and opportunities presented by the growing amount of available “real Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,